Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: A critical review of intervention design, pharmacist and patient perspectives

International Journal of Pharmacy Practice

Volumn 13, Issue 4, 2005, Pages 231-240

  Blenkinsopp, Alison ^a   Hassey, Alan ^b,c  

^a KEELE UNIVERSITY   (United Kingdom)

^b Fisher Medical Centre   (United Kingdom)

^c MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNITY CARE; COST BENEFIT ANALYSIS; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 28544433320     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.13.4.0001     Document Type: Review

References (29)

1. Carter S, Taylor D. A question of choice: Compliance in medicine-taking. London: Medicines Partnership; 2003.
2. Donnan PT, MacDonald TM, Morrist AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. UK DARTS/MEMO collaboration. Diabet Med 2002; 19:279-84.
3. Guidance on the care of people with diabetes. London: Royal Pharmaceutical Society of Great Britain; 2004.
4. Pharmaceutical Services Negotiating Committee. Diabetes services: a guide for community pharmacists, 2002. www. psnc.org.uk (accessed August 5, 2005)
5. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
6. Pharmaceutical Services Negotiating Committee. New contract: enhanced services, 2004. www.psnc.org.uk (accessed August 5, 2005)
7. Norris SL, Nichols PJ, Caspersen CJ et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med 2002;22:15-38.
8. Nichols-English GJ, Provost M, Koompalum D, Chen H, Athar M. Strategies for pharmacists in the implementation of diabetes mellitus management programmes. Dis Manage Health Outcomes 2002;10:783-803.
9. Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus (Cochrane Review). The Cochrane Library Issue 2. Oxford: Update Software; 2005.
10. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173-84.
11. Bliss E, Codack H, Boothe J. Diabetes care - an evaluation of a community pharmacy based HbA(1c) testing service. Pharm J 2001;267:264-6.
12. Berringer R, Shibley MC, Cary CC, Pugh CB, Rafi JA. Outcomes of a community pharmacy based diabetes monitoring program. J Am Pharm Assoc 1999;39:791-7.
13. Krass I, Stephenson S, Thuis I, Hourihan F, Taylor S, Armour C. Increasing adherence to medications through delivery of a disease management service for Type 2 diabetes in community pharmacies. J Soc Admin Pharm 2002;19:211.
14. Grant RW, Devita NG, Singer DE, Meigs JB. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother 2003;37:962-9.
15. Rajaei-Dehkordi Z, Hollingshead C, Herkes D, Holden M, Rao S. Investigating the contribution of community pharmacists in identifying, understanding and meeting the needs of patients with diabetes, in collaboration with other health care professionals. Int J Pharm Pract 2003;11:R18.
16. Swain JH, Macklin R. Individualised diabetes care in a rural community pharmacy. J Am Pharm Assoc 2001;41:458-61.
17. Cranor CW, Christensen D. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:160-72.
18. Cranor CW, Christensen D. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:149-59.
19. Abduelkarem AR, Sackville MA, Morgan RM, Hildreth AJ. An assessment of the level of type 2 diabetes patients' satisfaction with community pharmacists' services. Pharm J 2003;270:446-9.
20. Stewart D, O'Shea J, McCaig D. Agreement of practitioners with the recommendations of the 'Guidelines for community pharmacists on the care of patients with diabetes'. J Soc Admin Pharm 2003;20:13-17.
21. Timmer JW, de Smet PA, Schuling J, Tromp TF, de Jong-van den Berg LT. Patient education to users of oral hypoglycaemic agents: the perspective of Dutch community pharmacists. Pharm World Sci 1999;21:200-4.
22. Garrett DG, Martin LA. The Asheville project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program. J Am Pharm Assoc 2003;43:185-90.
23. Shane-McWhorter L, Fermo JD, Bultmeier NC, Oderda GM. National survey of pharmacist certified diabetes educators. Pharmacotherapy 2002;22:1579-93.
24. Douglas E, Chapman S, Hudson S, Paterson K, Duggan C. Patients' perspectives on medicines and pharmacy: views of patients with Type 2 diabetes. Int J Pharm Pract 2001;9(Suppl.):R76.
25. Brown C, Green A. Expectations of patients with diabetes for pharmaceutical care activities in community pharmacy settings. J Soc Admin Pharm 2000;17:219-23.
26. Davidson MB, Drew CR, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000;15:137-42.
27. Rothman R, Malone R, Bryant B, Horlen C, Pignone M. Pharmacist-led, primary care-based disease management improves haemoglobin A1c in high risk patients with diabetes. Am J Med Qual 2003;18:51-8.
28. Haugbolle LS, Devantier K, Frydenlund B. A user perspective on type 1 diabetes: sense of illness, search for freedom and the role of the pharmacy. Patient Educ Counsel 2002;47:361-8.
29. National Institute for Clinical Excellence. Guidance on the use of patient-education models for diabetes. Technology Appraisal 60; 2003. www.nice.org.uk (accessed August 5, 2005)